Patient P-02242
Therapy response
Improving
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
21%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S20
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability+5
- Nutritional resilience+3
- Treatment adherence+3
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients.
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 2.8 · butyrate capacity 49/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 67 ms
- Sleep
- 7.7 h
- Steps
- 7,047
- Resting HR
- 65 bpm
Daily log: GI score 22, nutritional resilience 66, adherence 92.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02277 | 42% | S05 | AD-05 | improved | 92 |
| P-02555 | 40% | S01 | AD-05 | no change | 79 |
| P-02282 | 45% | S01 | BR-03 | no change | 88 |
| P-02013 | 41% | S14 | BR-03 | no change | 94 |
| P-02483 | 29% | S06 | BR-03 | no change | 64 |
| P-02193 | 38% | S11 | CR-01 | improved | 87 |
| P-02354 | 31% | S01 | CR-01 | improved | 78 |
| P-02337 | 45% | S18 | DT-01 | no change | 100 |
| P-02081 | 40% | S20 | DT-01 | no change | 88 |
| P-02565 | 38% | S09 | DT-01 | no change | 79 |
| P-02249 | 36% | S09 | DT-01 | improved | 100 |
| P-02462 | 31% | S12 | DT-01 | improved | 65 |